Le Lézard
Classified in: Health, Science and technology
Subject: PER

KynderMed, Inc. Names Marc Lawrence as CEO


TALLAHASSEE, Fla., July 23, 2018 /PRNewswire-PRWeb/ -- The Company's Board of Directors has appointed Marc Lawrence as the CEO. According to Board Chairman and Partner at Newport Board Group, Don Rosenkoetter, "Marc is a proven senior executive with extensive experience in developing and accelerating profitable growth for Medical Device/Technology businesses. In addition to being intimate with the investor community, his global business development experience and acumen will deliver value to the customers we serve and our shareholders." Marc's background includes senior executive experiences at Johnson &Johnson, Philips Healthcare and HeartSine Technologies/Stryker.

Effective immediately, Melanie Simmons, PhD. President of KynderMed has assumed key strategic responsibilities as Chief Development Officer for the business. In her role, Melanie will be instrumental in product evolution and market development activities.

About KynderMed's Approach

KynderMed is employing novel proprietary technology developed by Dr. James Olcese, Professor of Biomedical Sciences, Neuroscience and Molecular Biophysics at Florida State University's College of Medicine.

The prospect of moving this technology to the women who so desperately need a safe and effective means to carry their babies to full term and avoid the tragedy that preterm birth creates a tremendous passion and energy among our team.

KynderMed is being advised by the Newport Board Group.

About KynderMed

KynderMed, Inc. is a Tallahassee Florida based Innovative medical device company with proprietary technology regulating uterine contractions in pregnant women. The technology will improve clinical outcomes by reducing preterm births, new born morbidity and lifelong disabilities.

Contact:
Melanie Simmons, PhD
President & CDO
msimmons(at)kyndermed.com
(850) 322-4629

 

SOURCE KynderMed, Inc.


These press releases may also interest you

at 13:56
Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors
Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patientsGastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a rare cancer that...

at 13:40
From 'the big one' to big relief for Adena Health heart attack patient
Jesse Patterson has always been more of a self-treatment type of guy when it comes to dealing with his health. So, when the normally active 73-year-old New Holland resident started getting short of breath and felt his lungs burning when he walked any...

at 13:12
Radians quarterly grassroots Tickets for Charity program empowers Midsouth nonprofits JIFF and The ARC Northwest Mississippi
Empowered by employee donations and matched by management contributions, Radians® quarterly Tickets for Charity (TFC) program champions local Memphis and Midsouth charities, offering crucial support for sustaining daily operations and expanding their...

at 13:07
Multi-talented Emmy® Award-Winning Host & Actress Tamera Mowry-Housley Set to Receive Trailblazer Award at A Pink Pump Affair
Multi-award-winning Civil Rights Attorney and Child Advocate, Areva Martin, in collaboration with the Special Needs Network (SNN), has revealed the distinguished honorees for the 16th Annual A Pink Pump Affair. This noteworthy charity event is...

at 13:05
Convergent Dental's "Solea User Group Meeting" Rebranded to "Solea Summit"
Convergent Dental, the power behind the Solea® All-Tissue Dental Laser, proudly announces the rebranding of its annual customer event from the "Solea User Group Meeting" to the "Solea Summit." This update reflects the evolution of the event into the...

at 13:00
Laniado Hospital Kicks Off Major Campaign For Building New Rocket-Proof Emergency Building In Netanya
The Laniado Hospital in Netanya, Israel, is embarking on a crucial initiative to construct the country's first fully sheltered emergency care building. With the support of the Laniado Development Fund, this endeavor aims to enhance public healthcare...

More news about Health...


News published on and distributed by: